Search results
AstraZeneca (AZN) Drugs Get CHMP Recommendation for Breast Cancer
Zacks via Yahoo Finance· 2 years agoThe EMA's Committee for Medicinal Products for Human Use recommends granting marketing approval to...
Seagen's (SGEN) Breast Cancer Study on Tuksya Combo Meets Goal
Zacks via Yahoo Finance· 10 months agoSeagen Inc. SGEN announced positive top-line results from its late-stage HER2CLIMB-02 study,...
Seagen's breast cancer therapy succeeds in late-stage study
Reuters via Yahoo News· 10 months agoPfizer in March agreed to acquire Seagen and its targeted therapies in a $43 billion deal to help...
Roche (RHHBY) Breast Cancer Drug Meets Primary Goal in Phase III
Zacks via Yahoo Finance· 7 months agoRoche's (RHHBY) phase III study evaluating inavolisib in combination with advanced hormone...
ASCO24: Can Ambrx’s novel ADC break into the metastatic breast cancer market?
Pharmaceutical Technology via Yahoo Finance· 3 weeks agoResults for the ACE-Breast-02 study were presented at the American Society of Clinical Oncology 2024...
Roche (RHHBY) Cancer Drug Gets Breakthrough Therapy Designation
Zacks via Yahoo Finance· 1 month agoRoche's (RHHBY) inavolisib gets Breakthrough Therapy Designation in the United States for advanced...
'I'm a people lover': Cancer patient volunteers for clinical trials to help others
Savannah Morning News via Yahoo News· 8 months agoCancer care is constantly improving at Lewis Cancer Research Pavilion and clinical trial...
ASCO24: Enhertu aims to replace Herceptin in first-line metastatic breast cancer
Pharmaceutical Technology via Yahoo Finance· 3 weeks agoInterim safety and efficacy results of the Phase Ib/II Destiny-BREAST07 trial with Enhertu...
'The hope of a fighter': Kennebunk woman runs 10K fundraiser to final chemo treatment
Portsmouth Herald via Yahoo News· 2 years agoWhat's the first thing a person would think to do after completing treatment for cancer? Bet it's...
Puma Biotech (PBYI) Stock up as Q2 Earnings & Sales Beat
Zacks via Yahoo Finance· 2 years agoShares of Puma Biotechnology PBYI were up 17.4% at market close on Aug 5, following the earnings...